Hua Medicine (Shanghai) Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	370.66	255.89	76.61	17.6	-	-
Other Revenue	-	-	-	-	-	8.66
Revenue	370.66	255.89	76.61	17.6	-	8.66
Revenue Growth (YoY)	240.24%	234.02%	335.31%	-	-	-61.07%
Cost of Revenue	175.88	131.17	39.24	9.91	-	-
Gross Profit	194.78	124.72	37.37	7.69	-	8.66
Selling, General & Admin	265	269.94	203.9	145.28	134.84	140.08
Research & Development	161.14	215.09	171.54	129.53	186.84	220.96
Operating Expenses	426.13	485.03	375.44	274.81	321.67	361.05
Operating Income	-231.35	-360.31	-338.07	-267.12	-321.67	-352.38
Interest Expense	-8.7	-8.61	-7.91	-3.67	-3.95	-4.4
Interest & Investment Income	15.33	13.44	16.51	4.24	5.04	4.37
Currency Exchange Gain (Loss)	-0.15	2.02	4.14	26.03	-10.37	-41.83
Other Non Operating Income (Expenses)	1,301	103.32	114.09	37.27	4.88	-1.72
EBT Excluding Unusual Items	1,076	-250.14	-211.23	-203.25	-326.08	-395.96
Merger & Restructuring Charges	-	-	-	-0.26	-	-
Other Unusual Items	-	-	-	-	0.35	2.83
Pretax Income	1,076	-250.14	-211.23	-203.51	-325.73	-393.13
Earnings From Continuing Operations	1,076	-250.14	-211.23	-203.51	-325.73	-393.13
Net Income	1,076	-250.14	-211.23	-203.51	-325.73	-393.13
Net Income to Common	1,076	-250.14	-211.23	-203.51	-325.73	-393.13
Shares Outstanding (Basic)	984	981	977	967	957	951
Shares Outstanding (Diluted)	987	981	977	967	957	951
Shares Change (YoY)	0.69%	0.44%	1.07%	0.97%	0.73%	0.90%
EPS (Basic)	1.09	-0.25	-0.22	-0.21	-0.34	-0.41
EPS (Diluted)	1.09	-0.25	-0.22	-0.21	-0.34	-0.41
Free Cash Flow	-283.53	-420.8	879.63	-234.67	-293.18	-45.27
Free Cash Flow Per Share	-0.29	-0.43	0.90	-0.24	-0.31	-0.05
Gross Margin	52.55%	48.74%	48.79%	43.69%	-	100.00%
Operating Margin	-62.42%	-140.80%	-441.28%	-1517.80%	-	-4067.20%
Profit Margin	290.30%	-97.75%	-275.73%	-1156.36%	-	-4537.56%
Free Cash Flow Margin	-76.49%	-164.44%	1148.19%	-1333.44%	-	-522.55%
EBITDA	-217.29	-345.99	-322.24	-254.82	-309.69	-347.43
EBITDA Margin	-58.62%	-135.21%	-	-	-	-
D&A For EBITDA	14.06	14.32	15.83	12.3	11.98	4.95
EBIT	-231.35	-360.31	-338.07	-267.12	-321.67	-352.38
EBIT Margin	-62.42%	-140.80%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.